| Literature DB >> 32603336 |
Jakub Stępnik1, Agnieszka Kędra2, Dariusz Czaprowski3,4.
Abstract
BACKGROUND: Respiratory system diseases are some of the most common pathologies worldwide. Although osteopathic manual therapy (OMT) is used predominantly to treat other pathologies, certain OMT techniques have been shown to improve patients' respiratory function.Entities:
Mesh:
Year: 2020 PMID: 32603336 PMCID: PMC7326176 DOI: 10.1371/journal.pone.0235308
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The pulmonary parameters in experimental and placebo groups before the study.
| Parameter | Group | Median | Min | 1st Qu | 3rd Qu | Max | |
|---|---|---|---|---|---|---|---|
| FVC | Experimental | 4.0 | 2.5 | 2.8 | 4.9 | 5.3 | 0.66 |
| Placebo | 3.9 | 2.5 | 3.6 | 4.2 | 5.7 | ||
| FEV1 | Experimental | 3.7 | 2.1 | 2.7 | 4.1 | 4.6 | 0.48 |
| Placebo | 3.5 | 1.8 | 3.2 | 3.6 | 4.5 | ||
| PEF | Experimental | 7.1 | 2.8 | 5.5 | 8.4 | 11.2 | 0.18 |
| Placebo | 8.2 | 5.1 | 7.0 | 9.3 | 11.9 |
FVC—Forced Vital Capacity; FEV1—Forced Expiratory Volume in 1 second; PEF—Peak Expiratory Flow
Pulmonary parameters before and after OMT and STT observed in experimental and placebo groups.
| Parameter | Group | Median | Min | 1st Qu | 3rd Qu | Max | ||
|---|---|---|---|---|---|---|---|---|
| FVC | Experimental | Before | 4.0 | 2.5 | 2.8 | 4.9 | 5.3 | 0.07 |
| After | 4.5 | 2.7 | 3.2 | 5.1 | 5.7 | |||
| Placebo | Before | 3.9 | 2.5 | 3.6 | 4.2 | 5.7 | 0.98 | |
| After | 4.2 | 2.6 | 3.6 | 4.4 | 5.5 | |||
| FEV1 | Experimental | Before | 3.7 | 2.1 | 2.7 | 4.1 | 4.6 | 0.14 |
| After | 3.9 | 2.5 | 2.8 | 4.3 | 4.5 | |||
| Placebo | Before | 3.5 | 1.8 | 3.2 | 3.6 | 4.5 | 0.3 | |
| After | 3.5 | 1.9 | 3.4 | 3.7 | 4.6 | |||
| PEF | Experimental | Before | 7.1 | 2.8 | 5.5 | 8.4 | 11.2 | |
| After | 8.1 | 4.8 | 6.7 | 9.3 | 12.2 | |||
| Placebo | Before | 8.2 | 5.1 | 7.0 | 9.3 | 11.9 | 0.95 | |
| After | 8.7 | 5.2 | 7.0 | 9.4 | 11.9 |
OMT—Osteopathic Manual Therapy; STT—soft tissue therapy; FVC—Forced Vital Capacity; FEV1—Forced Expiratory Volume in 1 second; PEF—Peak Expiratory Flow; significant difference was marked in bold
Pulmonary parameters in experimental and placebo groups after OMT and STT.
| Parameter | Group | Median | Min | 1st Qu | 3rd Qu | Max | |
|---|---|---|---|---|---|---|---|
| FVC | Experimental | 4.5 | 2.7 | 3.2 | 5.1 | 5.7 | 0.32 |
| Placebo | 4.2 | 2.6 | 3.6 | 4.4 | 5.5 | ||
| FEV1 | Experimental | 3.9 | 2.5 | 2.8 | 4.3 | 4.5 | 0.43 |
| Placebo | 3.5 | 1.9 | 3.4 | 3.7 | 4.6 | ||
| PEF | Experimental | 8.1 | 4.8 | 6.7 | 9.3 | 12.2 | 0.87 |
| Placebo | 8.7 | 5.2 | 7.0 | 9.4 | 11.9 |
OMT—Osteopathic Manual Therapy; STT—soft tissue therapy; FVC—Forced Vital Capacity; FEV1—Forced Expiratory Volume in 1 second; PEF—Peak Expiratory Flow